Atlas Trials

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

Clinical trial NCT02542215 · TERMINATED

Trial details

NCT number
NCT02542215
Sponsor
Sucampo Pharma Americas, LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Oral Mucositis
Start date
2015-06-01
Primary completion
2016-07-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.